Basic Information
TNAX Biopharma is a developer of pharmaceuticals aimed at improving patients' quality of life. The company’s drugs provide novel antibody therapies that target the interaction between immune receptors and their ligands, enabling patients to receive the treatments needed for refractory diseases.
TNAX Biopharma Corp.
Tokyo,Tokyo,Japan
101~500 people
January 01, 2018
--

